SBI Securities’s Mereo BioPharma MREO Stock Holding History

SBI Securities’s Portfolio MREO Stock Details MREO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-114	Closed	-$36	–	4181
2026 Q2	$36	Hold	114	–	–	﹤0.01%	3742
2026 Q1	$38	Buy	+114	New	+$49	﹤0.01%	3630

Other funds holding MREO

James J. Burns & Company Melville, New York $937M AUM 13.35% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SBI Securities's MREO Position: Q3 2026 in Review

SBI Securities sold out of Mereo BioPharma (MREO) in Q3 2026, closing a stake of 114 shares — an estimated $36 sold.

SBI Securities first reported a position in MREO in Q1 2026 and held it in 2 quarters. The position peaked at $38 in Q1 2026. 3 funds tracked by Wall St. Rank hold MREO as of Q3 2026.

SBI Securities reported no remaining Mereo BioPharma position as of Q3 2026 after selling out during the quarter.
SBI Securities sold 114 Mereo BioPharma shares in Q3 2026, an estimated $36.
SBI Securities first reported a position in Mereo BioPharma in Q1 2026 and held it in 2 quarters.
SBI Securities's Mereo BioPharma position peaked at $38 in Q1 2026.
3 funds tracked by Wall St. Rank held Mereo BioPharma as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.